Guru Ownership Trend
Guru Analysis for Maze Therapeutics, Inc. (MAZE)
Maze Therapeutics, Inc. (MAZE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $5 M.
Top institutional holders include Renaissance Technologies and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $2.24 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2025)
Guru Consensus (Q3 2025)
FAQs for Maze Therapeutics, Inc. (MAZE)
Major holders include Renaissance Technologies ($2.23 M), Cliff Asness ($716,057). According to the latest reported data, 2 tracked investment managers collectively hold approximately 113,715 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.24 M, with 2 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in MAZE during the most recent reporting period.
Yes, 1 managers opened new positions in MAZE, and 1 increased their existing holdings. The total reported buy value was $2.24 M.